Details of the Drug | DrugMAP

General Information of Drug (ID: DM2GFPX)

Drug Name

A-623

Synonyms

ZINC48553401

Indication

Disease Entry	ICD 11	Status	REF
Systemic lupus erythematosus	4A40.0	Phase 2/3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C16H15N3OS2
Canonical SMILES: CC1=C(SC(=N1)NC(=S)N)C(=O)C=CC=CC2=CC=CC=C2
InChI: 1S/C16H15N3OS2/c1-11-14(22-16(18-11)19-15(17)21)13(20)10-6-5-9-12-7-3-2-4-8-12/h2-10H,1H3,(H3,17,18,19,21)/b9-5+,10-6+
InChIKey: BOEHSSIGBYYFMA-NXZHAISVSA-N

Cross-matching ID

PubChem CID: 51059404
TTD ID: D02LPY

References

1	ClinicalTrials.gov (NCT01609452) MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP. U.S. National Institutes of Health.